CRP and COVID-19: Recent studies have shown that elderly patients with multiple comorbidities and high levels of inflammatory markers usually have a higher mortality risk than others [5,6]. A recent study published in March 2021 showed that male sex, lymphopenia, elevated C-reactive protein (CRP), and presence of comorbidities are all potential risk factors for poor outcomes in COVID-19 patients [7].